This is an old revision of the document!
COVID-19 Therapeutics Task Force
Members
Members |
Name | Position | Affiliation(s) |
Nancy Harrison | Co-chair | Life Sciences British Columbia, Ventures West, MSI Methylation Sciences, Creative Destruction Lab, adMare BioInnovations, Digital Technology Supercluster, Genome British Columbia, Knight Therapeutics |
Cédric Bisson | Co-chair | Teralys Capital, iNovia Capital, McKinsey & Company, Montreal InVivo, Grand Challenges Canada, Procure |
Maha Katabi | Member | Sofinnova, Amplyx Pharmaceuticals, Northsea Therapeutics, Oxalis Capital, Sectoral Asset Management, Ventures West Management, T2C2 Capital, Exactis Innovation |
Gordon McCauley | Member | adMare BioInnovations, Viable Healthworks, Allon Therapeutics, NDI Cpaital, BIOTECanada, CGen, Life Sciences British Columbia, Biotechnology Innovation Organization (BIO), Acetech, Toronto Rehabilitation Institute, Toronto Rehab Foundation |
Parimal Nathwani | Member | Toronto Innovation Acceleration Partners (TIAP), MaRS Discovery District, UBC University Industry Liaison Office (UILO), TRIUMF Innovations, Zucara Therapeutics, Vasomune Therapeutics, Encycle Therapeutics |
Ali Tehrani | Member | Zymeworks, Student Biotechnology Network (SBN), Consortium de recherche biopharmaceutique (CQDM), Life Sciences British Columbia, Mitacs, BIOTECanada, Premier's Technology Council, Creatus Biosciences |
Youla Tsantrizos | Member | McGill University, Boehringer Ingelheim, Centre de recherche en biologie structurale (CRBS), Canadian Society for Chemistry, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), Ontario Institute for Cancer Research (OICR) |
Advisors |
Lisa Barrett | Advisor | Dalhousie University, Senescence Aging Infection & Immunity Lab (SAIL), National Institute of Allergy and Infectious Diseases (NIAID) |
Marceline Côté | Advisor | University of Ottawa |
Eleanor Fish | Advisor | University of Toronto, University Health Network (UHN) |
Matthias Götte | Advisor | Li Ka Shing Institute of Virology, McGill University |